The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Racial and ethnic disparities in the availability and quality of substance abuse treatment are of interest to both policy makers and treatment service providers. A number of studies have indicated greater unmet needs for health services and poorer health outcomes for persons from racial or ethnic minority groups across a range of disease areas, including cardiovascular disease, mental disorders, diabetes, and other chronic and infectious diseases ( 1 ). However, there has been little research on the service needs, utilization, and outcomes of African Americans and Hispanics in substance abuse treatment.

Few studies have examined the service needs of persons from racial or ethnic minority groups in substance abuse treatment. Some studies have indicated that among persons in drug treatment, Hispanics have more severe substance use ( 2 ) and employment problems ( 2 , 3 ) than do African Americans or whites. Legal difficulties upon treatment admission have received more attention in the literature. Although some studies have found no ethnic differences in the severity of legal problems between Hispanic and white clients upon treatment admission ( 3 , 4 ), others have reported that Hispanics enter treatment with a greater number of prior arrests and more prior jail time than whites ( 5 ). Similarly, another study found that Hispanics and African Americans were more likely than whites to have criminal justice involvement and to have been referred by the legal system ( 6 ). Additional research is needed to improve our understanding of individuals' clinical and psychosocial functioning upon entry into treatment so that care can be improved.

Previous studies indicate that compared with non-Hispanic whites, African Americans and Hispanics report less access to mental health and substance abuse treatment services and less utilization of and satisfaction with such services ( 7 , 8 , 9 , 10 , 11 ). Among methamphetamine abusers in community treatment, compared with Hispanics, whites received a greater number of services overall and, in particular, a greater number of services addressing their alcohol and psychiatric problems ( 3 ). Another study also reported Hispanics' infrequent use of psychiatric services, as well as African Americans' reduced likelihood to utilize legal services despite greater need in this area ( 12 ).

The findings regarding substance abuse treatment retention are less consistent. Both African Americans and Hispanics have been found to have shorter treatment retention and less likelihood of completing treatment compared with whites ( 13 , 14 ), and African Americans were more likely than whites to be unfavorably discharged from an outpatient program (that is, they quit or were expelled from treatment) ( 15 ). Other studies, however, report no ethnic differences in regard to treatment retention ( 3 , 16 , 17 ).

Compared with white clients, narcotic-dependent Hispanics have consistently shown poor outcomes, including a more severe course of drug addiction, less likelihood of abstinence, and greater likelihood of daily drug use and incarceration ( 18 , 19 , 20 , 21 ). Few studies have examined racial and ethnic differences in outcomes of individuals who abuse drugs other than narcotics, and most have found no significant racial or ethnic differences in alcohol, drug, legal, or psychiatric outcomes ( 3 , 4 , 12 , 22 ). The exceptions have been findings that compared with whites, Hispanics were more likely to have better family and social outcomes ( 3 ) and to have a shorter time to relapse following treatment for methamphetamine abuse ( 23 ). Also, in a study of drug offenders, African Americans had poorer employment outcomes compared with Hispanics and whites ( 12 ). There is a notable lack of research examining African American and Hispanic substance abuse outcomes.

The study presented here is based on a large treatment outcome study completed in California. Previous cost-benefit analysis based on these data has shown overall cost-effectiveness of treatment. Specifically, every dollar invested in treatment was associated with $7 returned to society ( 24 ). Prior publications have also examined ethnic and gender differences among methamphetamine users ( 3 , 25 ) and treatment utilization and outcomes among Native Americans and Asian Americans ( 26 , 27 ).

The goal of this study was to examine racial and ethnic differences in service needs, treatment utilization, and outcomes among African-American, Hispanic, and white clients. In this article, we use the term Hispanic to include Mexican Americans, Puerto Ricans, Cubans, and South and Central Americans, and we use the terms whites and African Americans to refer to non-Hispanic whites and African Americans. We hypothesized that compared with whites, African Americans and Hispanics would receive fewer services and have poorer treatment outcomes. Our study objective was to contribute empirical data on how race-ethnicity is related to alcohol, drug, and psychosocial outcomes and, in turn, to help in determining whether treatments need to be adapted to improve outcomes among different racial and ethnic groups.

Methods

Study design

CalTOP (California Treatment Outcome Project) is a multisite, multicounty, prospective treatment outcome study that is part of the national Treatment Outcomes and Performance Pilot Studies Enhancement ( 28 ). Data collection began in April 2000 from all adult patients consecutively admitted to 43 substance abuse treatment programs in 13 counties in California. The participating programs covered wide geographic locations (for example, the northern, central, and southern regions of California), included both urban and rural areas, and consisted of the following treatment modalities: 25 outpatient drug-free (nonmethadone), 11 residential, four methadone maintenance, and three multiple modality. All study procedures were approved by the institutional review board at the University of California, Los Angeles (UCLA), and at the California Health and Human Services Agency, and informed consent was obtained at intake.

All participants were assessed at intake, and a subsample was assessed at three months and nine months after treatment admission. Individuals who entered CalTOP treatment between April 1, 2000, and May 31, 2001, were targeted for follow-up. Intake assessments were completed by treatment staff at participating programs, and follow-up phone interviews were conducted by UCLA interviewers. Assessments took approximately 30 minutes, and patients were paid $10 for the three-month interview and $15 for the nine-month interview. Administrative records were obtained for the entire sample covering the 12 months after treatment admission.

Participants

The study included 2,401 African-American, 3,222 Hispanic, and 7,980 white participants who entered treatment in a participating CalTOP treatment program. Demographic characteristics of the sample are presented in Table 1 . Among those targeted for the three-month follow-up, the follow-up rate was 83% (N=441 of 531) for African Americans, 79% (N=487 of 616) for Hispanics, and 82% (N=1,217 of 1,484) for whites. Among those targeted for the nine-month follow-up, the follow-up rate was 84% (N=515 of 613) for African Americans, 78% (N=571 of 732) for Hispanics, and 84% (N=1,480 of 1,762) for whites. Attrition analyses of those who did and did not complete the follow-up interviews revealed no significant differences in primary drug or employment status. However, men were less likely than women to complete both the three- and nine-month interviews, and those who had legal problems at baseline were less likely to complete the nine-month interview. There were no racial or ethnic differences in attrition at three months, but Hispanics were less likely than African Americans and whites to complete the nine-month interview.

Table 1 Characteristics of sample at treatment admission into substance abuse treatment, by race and ethnicity
Table 1 Characteristics of sample at treatment admission into substance abuse treatment, by race and ethnicity
Enlarge table

Measures

Addiction Severity Index (ASI). The ASI ( 29 ), which was administered at both intake and the nine-month follow-up, is a structured interview that assesses problem severity in seven areas: alcohol use, drug use, employment, family and social relationships, legal, medical, and psychological. A composite score was calculated for each scale. Possible scores range from 0 to 1, with higher scores indicating greater problem severity ( 30 ). The validity of the ASI has been demonstrated in racially and ethnically diverse populations, and it is the most commonly used instrument in the substance abuse field ( 29 , 31 ).

Treatment services review (TSR). The TSR ( 32 ) was administered at the three-month follow-up and assessed services received during treatment. The TSR documents the number of services received in the past three months in each of the seven domains of the ASI. Both services within and outside of the treatment program were included in this assessment.

Treatment retention. Treatment retention was defined as the number of days between treatment admission and treatment discharge and was based on treatment records provided by the state database. For individuals without discharge records, retention was calculated as the number of days between treatment admission and the last day receiving services or the date of the nine-month follow-up interview.

Arrests and driving under the influence (DUI) charges. Official records on arrests and charges of driving while under the influence of alcohol or drugs were obtained from the California Department of Justice and the California Department of Motor Vehicles.

Analytic approach

Group differences in pretreatment characteristics, treatment utilization, and treatment retention were examined with chi square tests for categorical variables and analysis of variance for continuous variables. Pairwise post hoc comparisons were conducted if the main group effect was significant. To further examine treatment retention, analysis of covariance (ANCOVA) was used to control for demographic variables, treatment modality, and baseline problem severity. In regard to outcome data, paired t tests were first used to examine changes in ASI composite scores from admission to follow-up. ANCOVA was used to examine differences between groups on ASI composite scores while controlling for covariates (demographic characteristics, treatment modality, baseline problem severity, and treatment retention). Finally, we used logistic regression analyses to examine the occurrence of arrest and DUI charges after treatment admission. To control for type I error, the significance level was set at p<.01.

Results

Demographic and pretreatment characteristics

Demographic variables and pretreatment characteristics were compared across the three ethnic groups by utilizing ANOVAs and chi square analyses ( Table 1 ). There were significant age differences between the three groups, with Hispanics being the youngest, followed by whites and then African Americans. Hispanics were more likely than the other two groups to be male and to have less education. There were significant employment differences between the groups, with Hispanics most likely to be employed full-time, followed by whites and then African Americans. Hispanics were the most likely to be married, whereas a greater proportion of whites were previously married and a greater proportion of African Americans had never married.

Differences in treatment setting were found between the three groups, with African Americans and whites more likely than Hispanics to be in residential treatment. There were significant differences in the primary drug used, with a greater proportion of African Americans using crack or cocaine, a greater proportion of Hispanics using opiates and methamphetamine, and a greater proportion of whites using alcohol and methamphetamine. Whites began using their primary drug at a younger age than the other groups, followed by Hispanics and then African Americans. In regard to alcohol treatment, white clients rated the importance of receiving alcohol treatment higher than the other two groups. They had also received treatment for alcohol a greater number of times, followed by African Americans and then Hispanics. In regard to drug treatment, the three groups did not differ in how important drug treatment was to them or the number of times they had previously experienced drug detoxification. However, African Americans had received a greater number of prior drug treatments.

In terms of legal status, African Americans and Hispanics were more likely than whites to be on parole, but a greater proportion of whites had charges pending. The three groups did not differ in regard to the number of lifetime convictions that they had, but there were differences in the number of months that they had been incarcerated, with African Americans having been incarcerated for the longest period of time, followed by Hispanics and then whites.

All three groups had similar severity of drug and legal problems upon treatment entry. Whites entered treatment with greater severity of alcohol and family problems, compared with the other two groups. In regard to employment, African Americans had the greatest problem severity, followed by Hispanics and then whites. Patterns of severity were similar for medical and psychiatric problems, with whites reporting the greatest problem severity, followed by African Americans and then Hispanics.

Treatment retention and service utilization

Data on treatment retention were available for the whole sample as they were based on administrative records. Hispanics remained in treatment for a significantly greater number of days (mean±SD=125.7±102.6 days) than did African Americans (mean=108.0± 94.7 days) or whites (mean=107.0± 100.7 days) (F=7.42, df=2 and 2,525, p<.001). Because the three groups differed on several demographic variables and baseline problem severity, ANCOVA was used to determine whether there were differences in treatment retention after controlling for age, gender, employment and marital status, treatment modality, and baseline severity of alcohol and drug problems. With these covariates in the model, there were no racial or ethnic differences in treatment retention.

Table 2 shows the total number of services received in different domains of treatment by racial and ethnic group. ANCOVA was used to determine whether there were differences in service utilization after controlling for age, gender, employment and marital status, treatment modality, and baseline problem severity in the respective domain. Compared with the other two groups, whites tended to receive a significantly greater number of alcohol treatment services and African Americans tended to receive a significantly greater number of employment services. The three groups did not differ in regard to service use for drug, family, legal, medical, or psychiatric problems.

Table 2 Number of services received three months after entering a substance abuse treatment program in California, by race and ethnicity
Table 2 Number of services received three months after entering a substance abuse treatment program in California, by race and ethnicity
Enlarge table

Treatment outcomes

Paired t tests were used to assess changes in ASI composite scores from admission to follow-up at nine months ( Table 3 ). All three groups showed significant reductions in severity of alcohol, drug, employment, family, legal, and psychiatric problems. Whites were the only group to significantly improve in the medical problem domain. Racial and ethnic differences in treatment outcomes were analyzed by using ANCOVA while controlling for age, gender, employment and marital status, treatment modality, treatment retention, and baseline ASI score. Significant differences were found in scores in the alcohol domain, with whites having poorer alcohol outcomes than African Americans and Hispanics (F=5.3, df=2 and 2,498, p<.01). Whites also had less favorable legal outcomes compared with Hispanics (F=4.67, df=2 and 2,493, p<.01). There was also a trend for whites to have worse outcomes in the psychiatric domain (F=4.02, df=2 and 2,464, p=.02) and better outcomes in the employment domain (F=3.78, df=2 and 2,485, p=.02) compared with the other two groups. There were no group differences in drug, family, or medical outcomes.

Table 3 Addiction Severity Index (ASI) composite scores at admission and nine-month follow-up, by race and ethnicity
Table 3 Addiction Severity Index (ASI) composite scores at admission and nine-month follow-up, by race and ethnicity
Enlarge table

Arrest rates for the year after treatment admission were 23.1% (N=119) for African Americans, 23.5% (N=134) for Hispanics, and 19.1% (N=283) for whites. Logistic regression controlling for age, gender, employment and marital status, and treatment modality indicated a trend for African Americans to have a greater likelihood of being arrested, compared with whites (odds ratio [OR]=1.3, 95% confidence interval [CI]=1.1–1.7, p=.02). DUI rates for the year after treatment admission were .9% for African Americans, 1.7% for Hispanics, and 2.5% for whites. Logistic regression controlling for the same variables as the prior analysis indicated that African Americans were significantly less likely than whites to be charged with a DUI (OR=.36, CI=.22–.58, p<.001) and that Hispanics were less likely than whites to get a DUI, although the latter finding was not significant (OR=.69, CI=.49–.96, p=.03).

Discussion

This study examined the pretreatment client characteristics, service utilization, and treatment retention and outcomes of African-American, Hispanic, and white clients in community substance abuse programs in California. Compared with whites, persons from racial and ethnic minority groups entered substance abuse treatment with significantly less problem severity in a number of domains, including alcohol, family, medical, and psychiatric. They were also less likely to have legal charges pending. Employment was the one area in which African Americans and Hispanics had greater problem severity than whites, perhaps reflecting broader community employment difficulties in these groups. Despite similarity in severity of alcohol and drug problems among African Americans and Hispanics in this sample, Hispanics were the least likely to receive residential treatment services. This is similar to prior observations of drug offenders in community-based treatment and individuals in treatment for alcohol and methamphetamine ( 3 , 12 , 33 ). This disparity in placement in outpatient versus residential treatment, which may be a result of cultural values, should be further investigated in future studies.

Although treatment retention did not differ between the three groups, significant differences were found in the degree to which some services were accessed. The only area of discrepancy between problem severity and service utilization for Hispanics was in the domain of employment. Although Hispanics had greater employment problems than whites at treatment admission, they did not differ from whites in the number of employment-related services that they received and had poorer employment outcomes than whites. It is unclear what factors may have contributed to Hispanics' lower use of employment services and poorer outcomes. Possible hypotheses include client factors (for example, lower education and job skills, language barriers, perceived stigma, and legal concerns of undocumented immigrants), treatment factors (for example, shortage of Spanish-speaking employment specialists), or exterior barriers such as inaccessibility (for example, cost and transportation).

Other differences in service utilization were also found. White clients received more alcohol treatment services than did African Americans or Hispanics, and African Americans received a greater number of employment services than did white or Hispanic clients. Both of these findings appear to be a reflection of service needs, as whites had the greatest alcohol problem severity and African Americans had the greatest employment problem severity at treatment admission.

Contrary to our hypotheses, whites had poorer alcohol outcomes than African Americans and Hispanics, poorer legal outcomes than Hispanics, and a greater likelihood of getting a DUI than African Americans. There was also a trend for whites to have poorer psychiatric outcomes and better employment outcomes than the other two groups. However, they attained outcomes comparable to those of African Americans and Hispanics in terms of ASI composite scores on drug, family, and medical outcomes. Because the effectiveness of treatment did not differ across race or ethnicity in these domains, it is possible that all three groups are responding to treatment in similar ways. Alternatively, the mechanisms by which patients reach a common endpoint may differ by race or ethnicity. Testing of mediational models would be valuable in identifying group differences in the pathway to recovery. Overall, the findings indicate that upon entering substance abuse treatment, African Americans and Hispanics seem to fare just as well, if not better, than whites on subsequent treatment outcomes in publicly funded, community-based programs.

Strengths of this study include the large, racially and ethnically diverse sample and the use of community-based treatment seekers. The inclusion of numerous treatment programs across California also increases the generalizability of our findings. Although the counties and treatment programs that participated in CalTOP were not randomly selected, the characteristics of the sample resemble those of the statewide treatment population in terms of gender, race and ethnicity, age, employment status, primary drug type, and legal status ( 28 ). It is important to note, however, that Hispanic participants were less likely than African-American and white participants to complete the nine-month follow-up assessment of treatment outcomes, and therefore the results for this group may be biased in some way. Attrition analyses also indicated that women were more likely than men to complete the three- and nine-month follow-up interviews, possibly limiting the generalizability of our findings on treatment utilization and outcomes to women.

Another limitation of the study is that the sample was based on persons receiving publicly funded treatment, thus the results may not be applicable to those receiving services in the private sector. Individuals receiving publicly funded treatment may have more severe disorders that interfere with their ability to obtain private insurance coverage. Given potential disparities in access to care, it is possible that community treatment programs may serve as the only treatment option for some persons from racial or ethnic minority groups and a last resort for whites. There is some evidence for this in that whites in this study entered treatment with the greatest problem severity in four of the seven domains examined.

Categories, such as Hispanic, comprise a heterogeneous group of people with potentially different outcomes. By combining these groups, it is possible that we masked the severity of problems experienced by some of these subgroups. The identification of sociocultural constructs that are more clinically meaningful is important. For example, studies have shown the effect of acculturation and immigration status on the prevalence of substance use disorders among Hispanics. However, their impact on service utilization and outcomes has not been examined.

Conclusions

Despite the study limitations, we believe that this study contributes important information regarding racial and ethnic differences among substance abusers treated in community-based programs. The data suggest that all three groups improved after treatment, and contrary to our hypothesis, persons from racial and ethnic minority groups did not experience poorer treatment outcomes, compared with whites. However, benefits from treatment can be further enhanced if services underscore different facets of clinical and psychosocial problems of individual racial and ethnic groups. Specifically, African Americans and Hispanics may benefit from increased employment services, and whites may benefit from increased alcohol, legal, and psychiatric services.

Acknowledgments and disclosures

This study was supported in part by grant 1-UR1-TI11478-01 from the California Department of Alcohol and Drug Programs under the Center for Substance Abuse Treatment TOPPS II (Treatment Outcomes and Performance Pilot Studies Enhancement), by grant RO1-DA-15431 from the National Institute on Drug Abuse, and by a grant from the Robert Wood Johnson Foundation Substance Abuse Policy Research Program. Dr. Niv was also supported by a National Institute on Drug Abuse Institutional National Research Service Award 5T32DA007272-15. Any opinions expressed are those of only the authors and do not necessarily represent the views of any affiliated institutions.

The authors report no competing interests.

Dr. Niv is affiliated with the Department of Veterans Affairs Desert Pacific Mental Illness Research, Education, and Clinical Center, 5901 East 7th St., Bldg. 128/J-213A, Long Beach, CA 90822 (e-mail: [email protected]). Dr. Niv is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, with which the other authors are affiliated.

References

1. Smedley BD, Stith AY, Nelson AR: Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC, National Academies Press, 2003Google Scholar

2. Kosten TR, Rounsaville BJ, Kleber HD: Ethnic and gender differences among opiate addicts. International Journal of Addictions 20:1143–1162, 1985Google Scholar

3. Niv N, Hser Y: Drug treatment service utilization and outcomes for Hispanic and white methamphetamine abusers. Health Services Research 41:1242–1257, 2006Google Scholar

4. Morgenstern J, Bux DA: Examining the effects of sex and ethnicity on substance abuse treatment and mediational pathways. Alcoholism: Clinical and Experimental Research 27:1330–1332, 2003Google Scholar

5. Anglin MD, Ryan TM, Booth MW, et al: Ethnic differences in narcotics addiction: I. characteristics of Chicano and Anglo methadone maintenance clients. International Journal of the Addictions 23:125–149, 1988Google Scholar

6. Rounds-Bryant JL, Staab J: Patient characteristics and treatment outcomes for African American, Hispanic, and white adolescents in DATOS-A. Journal of Adolescent Research 16:624–641, 2001Google Scholar

7. Alegria M, Canino G, Rios R, et al: Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatric Services 53:1547–1555, 2002Google Scholar

8. Daley MC: Race, managed care, and the quality of substance abuse treatment. Administration and Policy in Mental Health 32:457–476, 2005Google Scholar

9. Longshore D, Hsieh S, Anglin MD, et al: Ethnic patterns in drug abuse treatment utilization. Journal of Mental Health Administration 19:268–277, 1992Google Scholar

10. Padgett DK, Patrick C, Burns BJ, et al: Ethnicity and the use of outpatient mental health services in a national insured population. American Journal of Public Health 84:222–226, 1994Google Scholar

11. Wells K, Klap R, Koike A, et al: Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. American Journal of Psychiatry 158:2027–2032, 2001Google Scholar

12. Fosados R, Evans E, Hser Y: Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. Journal of Substance Abuse Treatment 33:391–399, 2007Google Scholar

13. Agosti V, Nunes E, Ocepeck-Welikson K: Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse 22:1–5, 1996Google Scholar

14. Milligan CO, Nich C, Carroll KM: Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Psychiatric Services 55:167–173, 2004Google Scholar

15. Brown BS, Joe, GW, Thompson P: Minority group status and treatment retention. Substance Use and Misuse 20:319–335, 1985Google Scholar

16. Grella CE, Anglin MD, Wugalter SE: Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug and Alcohol Dependence 37:15–21, 1995Google Scholar

17. Kleinman PH, Kang S, Lipton DS, et al: Retention of cocaine abusers in outpatient psychotherapy. American Journal of Drug and Alcohol Abuse 18:29–43, 1992Google Scholar

18. Anglin MD, Booth WM, Ryan TM, et al: Ethnic differences in narcotics addiction: II. Chicano and Anglo addiction career patterns. International Journal of the Addictions 23:1011–1027, 1988Google Scholar

19. Brecht ML, Anglin MD, Woodward JA, et al: Conditional factors of maturing out: personal resources and preaddiction sociopathy. International Journal of the Addictions 22:55–69, 1987Google Scholar

20. Prendergast ML, Hser Y, Gil-Rivas V: Ethnic differences in longitudinal patterns and consequences of narcotics addiction. Journal of Drug Issues 28:495–515, 1998Google Scholar

21. Long GL, Demaree RG: Indicators of criminality during treatment for drug abuse. American Journal of Drug and Alcohol Abuse 2:123–136, 1975Google Scholar

22. Lowman C, Le Fauve CE: Health disparities and the relationship between race, ethnicity, and substance abuse treatment outcomes. Alcoholism: Clinical and Experimental Research 27:1324–1326, 2003Google Scholar

23. Brecht ML, von Mayrhauser C, Anglin MD: Predictors of relapse after treatment for methamphetamine use. Journal of Psychoactive Drugs 32:211–220, 2000Google Scholar

24. Ettner SL, Huang D, Evans E, et al: Benefit-cost in the California Treatment Outcome Project (CalTOP): does substance abuse treatment "pay for itself"? Health Services Research 41:192–213, 2006Google Scholar

25. Hser Y, Evans E, Huang Y: Treatment outcomes among women and men methamphetamine abusers in California. Journal of Substance Abuse Treatment 28:77–85, 2005Google Scholar

26. Evans E, Spear SE, Huang YC, et al: Outcomes of drug and alcohol treatment programs among American Indians in California. American Journal of Public Health 96:889–896, 2006Google Scholar

27. Niv N, Wong EC, Hser Y: Asian Americans in community-based substance abuse treatment: a look at service needs, utilization and outcomes in California. Journal of Substance Abuse Treatment 33:313–319, 2007Google Scholar

28. Hser Y, Evans E, Teruya C, et al: Final Report: The California Treatment Outcome Project. California State Department of Alcohol and Drug Programs. Los Angeles, UCLA Integrated Substance Abuse Programs, 2002Google Scholar

29. McLellan AT, Kushner H, Metzger D, et al: The fifth edition of the Addiction Severity Index. Journal of Substance abuse Treatment 9:199–213, 1992Google Scholar

30. McGahan P, Griffith J, McLellan AT: Composite Scores From the Addiction Severity Index: Manual and Computer Software. Philadelphia, Veterans Administration Press, 1986Google Scholar

31. McLellan AT, Luborsky L, Cacciola J, et al: New data from the Addiction Severity Index: reliability and validity in three centers. Journal of Nervous and Mental Disease 173:412–422, 1985Google Scholar

32. McLellan AT, Alterman AI, Cacciola J, et al: A new measure of substance abuse treatment: initial studies of the treatment service review. Journal of Nervous and Mental Disease 180:101–110, 1992Google Scholar

33. Gilbert MJ, Cervantes RC: Mexican Americans and Alcohol. Monograph no 11. Los Angeles, Spanish Speaking Mental Health Research Center, 1987Google Scholar